| Toxicology study of single-walled carbon nanotubes and reduced graphene oxide in human sperm W Asghar, H Shafiee, V Velasco, VR Sah, S Guo, R El Assal, F Inci, ... Scientific reports 6 (1), 1-11, 2016 | 59 | 2016 |
| Kras is Required for Adult Hematopoiesis A Damnernsawad, G Kong, Z Wen, Y Liu, A Rajagopalan, X You, J Wang, ... Stem Cells 34 (7), 1859-1871, 2016 | 39 | 2016 |
| p53 −/− synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia J Zhang, G Kong, A Rajagopalan, L Lu, J Song, M Hussaini, X Zhang, ... Blood, The Journal of the American Society of Hematology 129 (3), 358-370, 2017 | 33 | 2017 |
| Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice Z Wen, A Rajagopalan, ED Flietner, G Yun, M Chesi, Q Furumo, RT Burns, ... Blood 137 (1), 61-74, 2021 | 32 | 2021 |
| Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation X You, F Liu, M Binder, A Vedder, T Lasho, Z Wen, X Gao, E Flietner, ... Blood, The Journal of the American Society of Hematology 139 (7), 1066-1079, 2022 | 27 | 2022 |
| Downregulating Notch counteracts Kras G12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm G Kong, X You, Z Wen, YI Chang, S Qian, EA Ranheim, C Letson, ... Leukemia 33 (3), 671-685, 2019 | 16 | 2019 |
| Nras Q61R/+ and Kras−/− cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors Z Wen, G Yun, A Hebert, G Kong, EA Ranheim, R Finn, A Rajagoplan, ... Blood, The Journal of the American Society of Hematology 137 (23), 3259-3271, 2021 | 6 | 2021 |
| Mice expressing MYC and NrasQ61R in germinal center B cells develop highly aggressive multiple myeloma A Rajagopalan, Z Wen, Q Furumo, EA Ranheim, R Finn, E Flietner, G Yun, ... Blood 132, 1006, 2018 | 4 | 2018 |
| Versican proteolytic fragments (matrikines) regulate the intratumoral dendritic cell milieu in vivo: implications for in situ tumor vaccination A Papadas, E Flietner, Z Morrow, J Wiesner, A Cicala, A Pagenkopf, ... Blood 134, 1210, 2019 | 3 | 2019 |
| Loss of Asxl1 Cooperates with Oncogenic Nras to Drive CMML Progression X You, Z Wen, G Kong, A Rajagopalan, EA Ranheim, Y Zhou, MM Patnaik, ... Blood 134, 3790, 2019 | 1 | 2019 |
| Expression of oncogenic Nras and a MYC transgene in germinal center B cells induces a highly malignant multiple myeloma Z Wen, A Rajagopalan, EA Ranheim, R Finn, A Pagenkopf, G Yun, ... Cancer Research 78 (13 Supplement), 3018-3018, 2018 | 1 | 2018 |
| Ponatinib for RAS-Driven Multiple Myeloma: Efficacy in the High-Risk VQ Myeloma Model E Flietner, Z Wen, A Rajagopalan, O Jung, J Wiesner, X You, Y Zhou, ... | | 2022 |
| Developing Novel Targeted Therapies Using the High-Risk Vq Myeloma Model E Flietner, Z Wen, A Rajagopalan, J Wiesner, X You, Y Zhou, T Lasho, ... Blood 136, 10-11, 2020 | | 2020 |
| Reconstructing the Clonal and Mutational Architecture of Myeloma through Avian Leukosis Virus (ALV)-Mediated Genome Editing Z Morrow, A Cicala, E Flietner, A Papadas, A Pagenkopf, Z Wen, ... Blood 132, 4480, 2018 | | 2018 |
